Definigen
Definigen
Investment Stage – Series A & B
Investment Stage – Series A & B
Definigen produces hIPSC derived hepatocytes, pancreatic beta cells and lung endothelial cells for use in drug discovery and toxicology testing for the biotech and pharma industry.

Definigen
Definigen
Investment Stage – Series A & B
Investment Stage – Series A & B
Definigen produces hIPSC derived hepatocytes, pancreatic beta cells and lung endothelial cells for use in drug discovery and toxicology testing for the biotech and pharma industry.
